Bavarian Nordic Teams Up with Serum Institute for Mpox Vaccine Production

In a significant development in the field of vaccine technology, Bavarian Nordic, a leading biotechnology company, has signed a landmark agreement with the Serum Institute of India. This collaboration aims to produce and supply a vaccine targeting mpox (formerly known as monkeypox) as the global health community continues to address emerging infectious diseases.

Continue reading